title: A Case Series of Patients With Psoriasis Exposed to Biologic Therapy During Pregnancy: The BIOBADADERM Register and a Review of the Literature.
authors.affiliation: Servicio de Dermatología, Hospital Universitario de Fuenlabrada, Madrid, España.
authors.forename: B
authors.initials: B
authors.lastname: Echeverría-García
authors.affiliation: Servicio de Dermatología, Hospital Universitario Rey Juan Carlos, Madrid, España.
authors.forename: A
authors.initials: A
authors.lastname: Nuño-González
authors.affiliation: Servicio de Dermatología IIS-IP, Hospital Universitario La Princesa, Madrid, España.
authors.forename: E
authors.initials: E
authors.lastname: Dauden
authors.affiliation: Servicio de Dermatología, Hospital Universitario 12 de Octubre, Madrid, España.
authors.forename: F
authors.initials: F
authors.lastname: Vanaclocha
authors.affiliation: Servicio de Dermatología, Hospital Universitario de Gran Canaria Dr. Negrín, Las Palmas de Gran Canaria, España.
authors.forename: R
authors.initials: R
authors.lastname: Torrado
authors.affiliation: Servicio de Dermatología, Hospital General Universitario de Alicante, Alicante, España.
authors.forename: I
authors.initials: I
authors.lastname: Belinchón
authors.affiliation: Unidad de Investigación, Fundación Academia Española de Dermatología y Venereología, Madrid, España; Unidad de Investigación, Gerencia de Atención Integrada de Albacete, Albacete, España. Electronic address: beatrizpzafrilla@gmail.com.
authors.forename: B
authors.initials: B
authors.lastname: Pérez-Zafrilla
mesh_terms: D000014:Abnormalities, Drug-Induced; D000028:Abortion, Induced; D000068879:Adalimumab / Q000009:adverse effects / Q000627:therapeutic use*; D016208:Databases, Factual; D003879:Dermatologic Agents / Q000009:adverse effects / Q000627:therapeutic use*; D000068800:Etanercept / Q000009:adverse effects / Q000627:therapeutic use*; D005260:Female; D005322:Premature Rupture of Fetal Membranes; D006801:Humans; D007231:Infant, Newborn; D008297:Male; D011247:Pregnancy; D011248:Pregnancy Complications / Q000188:drug therapy*; D011565:Psoriasis / Q000188:drug therapy*; D012042:Registries; D012127:Respiratory Distress Syndrome, Newborn; D000069549:Ustekinumab / Q000009:adverse effects / Q000627:therapeutic use*
chemical_list: D003879:Dermatologic Agents; D000069549:Ustekinumab; D000068879:Adalimumab; D000068800:Etanercept